Research for cancer treatment and the development of innovative treatments is at its best. Among various achievements, medicine Personalized treatment is one of the most important and shows how successful the medical community and the pharmaceutical industry have been in developing specific treatments for each patient.
These treatments are complex, expensive, and a coordinated effort is needed to understand the therapeutic benefits and associated risks. And, above all, that patients arrive as quickly as possible. Today, they have greater access to information and greater participation in public life, and demand transparency in research and greater engagement with government agencies with which to forge alliances to gain access to innovative treatments for the common good and better health for everyone.
Despite dizzying advances in personalized medicine research, adoption has not happened at the same rate and these treatments, which are revolutionizing the therapeutic approach to cancer, take a long time to reach those who need them, so an agreement is urgently needed between authorities, organizations and companies to make these treatments a reality.
WATCH: China: Cars plunge into river after bridge collapses due to heavy rains
The report “Personalized Medicine for Cancer Treatment: So Close and So Far” by the LLYC Healthcare team examines the need to reach an agreement between governments, organizations and companies using public-private collaboration models that promote patient dialogue, new relationships and persuasive story to accelerate the introduction of innovative drugs for cancer treatment.
Use data to better understand ideas patients and doctors. Thanks to AI (artificial intelligence) and the use of big data, we can now learn more about unmet needs and behaviors. Understanding the context in which treatment is diagnosed and administered can influence treatment planning. medical affairs, access, commercial strategy, communication and relationships. In addition, the use of new technologies, channels and trends in communication allows you to truly approach society.
Conduct an analysis of the public policy landscape and regulatory environment.. Here it is important to have a specialized team with knowledge of the healthcare ecosystem and therapeutic areas in order to understand current regulations or evaluate initiatives in favor of patients. The goal should be to work in coordination with decision makers to remove the barriers that prevent patients from accessing the most innovative therapies that help and save lives.
New storytelling based on innovation and collaboration through alliances. What is needed is a collaborative approach and action that brings innovation to those who need it most. This context provides a unique opportunity to create a narrative that positions companies as key players that can contribute to improving the condition of patients and healthcare systems.
“Personalized medicine for cancer is certainly taking a step forward, but it could move faster. Encouraging public-private alliances is critical to taking joint action and improving efforts to fight the disease. Willingness and urgent agreement is required between health authorities, pharmaceutical and biotech companies and all organizations in this sector, so that the achievements are not only encouraging, but also a reality in the short term for the patient.”says Javier Marin, senior director of Healthcare Americas.
In the Peruvian context, communication has always played a critical role in accelerating the introduction of innovative elements into the health sector. Thus, the need for compelling new storytelling and the strategic use of technology will remain allies in understanding the hidden needs of patients and clinicians.
Richard Arce analyzes the message of Dina Boluarte